نتایج جستجو برای: 656 and 634

تعداد نتایج: 16827774  

2005

During the next two weeks, floral-color change could be investigated in Aster divaricatus or A. prenanthoides, both of which grow on my property. You could investigate one or more of the above hypotheses relative to the situation in Aster. For example, you could investigate whether the presence of color-changed flowers enhances the plant as a visual target for pollinators as well as determine w...

2015
Jasmine M. McCammon Hazel Sive

The treatment of psychiatric disorders presents threemajor challenges to the research and clinical community: defining a genotype associated with a disorder, characterizing themolecular pathologyof eachdisorder anddevelopingnew therapies.ThisReviewaddresseshowcellularand animal systems can help to meet these challenges, with an emphasis on the role of the zebrafish. Genetic changes account for ...

2003

Floral-color Changes Floral-color changes are common among the angiosperms. At least three non-exclusive hypotheses have been proposed to explain these changes: 1. Once flowers are adequately pollinated, further pollinator visits impair reproduction by deposition of self-pollen, dislodging of pollen, or damage to floral parts. 2. Color changes mark flowers that have been depleted of their rewar...

Journal: :The Journal of endocrinology 2006
M Maamra A Milward H Zarkesh Esfahani L P Abbott L A Metherell M O Savage A J L Clark R J M Ross

Growth hormone insensitivity syndrome (GHIS) has been reported in a family homozygous for a point mutation in the GH receptor (GHR) that activates an intronic pseudoexon. The resultant GHR (GHR1-656) includes a 36 amino-acids insertion after residue 207, in the region known to be important for homodimerization of GHR. We have examined the functional consequences of such an insertion in mammalia...

Journal: :The Classical Review 1906

2004
John F Potter Peter S Sever Simon McG Thom Bryan Williams Neil R Poulter Morris J Brown Mark Davis Gordon T McInnes

http://bmj.com/cgi/content/full/328/7440/634 Updated information and services can be found at: These include: Data supplement http://bmj.com/cgi/content/full/328/7440/634/DC1 "Categories of strength used in statements" References http://bmj.com/cgi/content/full/328/7440/634#otherarticles 29 online articles that cite this article can be accessed at: http://bmj.com/cgi/content/full/328/7440/634#B...

Journal: :Bacteriological reviews 1966
P S Brachman A F Kaufman F G Dalldorf

INTRODUCTION ................................................................ ..........646 MATERIALS AND METHODS.................. 646 RESuLTS..................................................................... 650 DIscussIoN................................................................... 654 SUMMARY.................................................................... 656 LITERATURE CITED.....

2004

Floral-color Changes Floral-color changes are common among the angiosperms. At least three non-exclusive hypotheses have been proposed to explain these changes: 1. Once flowers are adequately pollinated, further pollinator visits impair reproduction by deposition of self-pollen, dislodging of pollen, or damage to floral parts. 2. Color changes mark flowers that have been depleted of their rewar...

Journal: :Journal 2009
Anjani Koneru Michael J Sigal

OBJECTIVES This study was undertaken to determine the proportion of persons primarily with developmental disabilities who encounter difficulties accessing dental care in Ontario, to identify perceived barriers to accessing dental care and to determine if persons with disabilities and their caregivers believe that oral health is important. METHODS Community organizations providing services mai...

Journal: :The Journal of pharmacology and experimental therapeutics 2017
Scott L Harbeson Adam J Morgan Julie F Liu Ara M Aslanian Sophia Nguyen Gary W Bridson Christopher L Brummel Lijun Wu Roger D Tung Lana Pilja Virginia Braman Vinita Uttamsingh

Ivacaftor is currently used for the treatment of cystic fibrosis as both monotherapy (Kalydeco; Vertex Pharmaceuticals, Boston, MA) and combination therapy with lumacaftor (Orkambi; Vertex Pharmaceuticals). Each therapy targets specific patient populations: Kalydeco treats patients carrying one of nine gating mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein, w...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید